Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06924489 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Jun 1, 2026 → Dec 1, 2026
See other at-risk trials from Xijing Hospital of Digestive Diseases

Record History

  1. Primary completion pushed from Jun 1, 2026 to Dec 1, 2026
    • Trial status changed: Unknown → Recruiting
    • Study completion pushed from Jul 1, 2026 to Dec 1, 2026
    • Study sites: 0 to 1
    v2
  2. Changed Registry marked status Unknown; last known: Not Yet Recruiting
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if 3-dimensional (3D) imaging device works to identify patients with high risk adenomas during colonoscopy to guide proper follow-up strategy. It will also learn about the safety of 3-dimensional (3D) imaging device. The main questions it aims to answer are: Does 3-dimensional (3D) imaging device improve the identification of patients with high risk adenomas? What adverse events do participants experience during colonoscopy? Researchers will compare 3-dimensional (3D) imaging device to traditional 2-dimensional (2D) imaging device to see if 3-dimensional (3D) imaging device works to improve high risk adenoma identification. Participants will: Undertake colonoscopy examination using 3-dimensional (3D) imaging device or 2-dimensional (2D) imaging device. Be followed-up to 30 days to record potential colonoscopy-relevant adverse events.
Trial Details
NCT Number NCT06924489
Lead Sponsor Xijing Hospital of Digestive Diseases
Collaborators: Beijing Friendship Hospital, Qilu Hospital of Shandong University
Conditions
(from sponsor)		 Colorectal Adenoma, Colorectal Polyps
Enrollment 1,566 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov